vs

Side-by-side financial comparison of AVISTA CORP (AVA) and CABOT CORP (CBT). Click either name above to swap in a different company.

CABOT CORP is the larger business by last-quarter revenue ($849.0M vs $533.0M, roughly 1.6× AVISTA CORP). AVISTA CORP runs the higher net margin — 13.3% vs 8.6%, a 4.7% gap on every dollar of revenue. On growth, AVISTA CORP posted the faster year-over-year revenue change (0.0% vs -11.1%). CABOT CORP produced more free cash flow last quarter ($57.0M vs $-116.0M). Over the past eight quarters, AVISTA CORP's revenue compounded faster (-6.5% CAGR vs -8.7%).

Avista Corporation is an American energy company which generates and transmits electricity and distributes natural gas to residential, commercial, and industrial customers. Approximately 1,550 employees provide electricity, natural gas, and other energy services to 359,000 electric and 320,000 natural gas customers in three western states. The service territory covers 30,000 square miles (78,000 km2) in eastern Washington, northern Idaho, and parts of southern and eastern Oregon, with a popul...

Cabot Corporation is an American specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company operates in over 20 countries with 36 manufacturing plants, eight research and development facilities, and 28 sales offices.

AVA vs CBT — Head-to-Head

Bigger by revenue
CBT
CBT
1.6× larger
CBT
$849.0M
$533.0M
AVA
Growing faster (revenue YoY)
AVA
AVA
+11.1% gap
AVA
0.0%
-11.1%
CBT
Higher net margin
AVA
AVA
4.7% more per $
AVA
13.3%
8.6%
CBT
More free cash flow
CBT
CBT
$173.0M more FCF
CBT
$57.0M
$-116.0M
AVA
Faster 2-yr revenue CAGR
AVA
AVA
Annualised
AVA
-6.5%
-8.7%
CBT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
AVA
AVA
CBT
CBT
Revenue
$533.0M
$849.0M
Net Profit
$71.0M
$73.0M
Gross Margin
24.9%
Operating Margin
21.0%
15.2%
Net Margin
13.3%
8.6%
Revenue YoY
0.0%
-11.1%
Net Profit YoY
5.7%
-21.5%
EPS (diluted)
$0.87
$1.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AVA
AVA
CBT
CBT
Q4 25
$533.0M
$849.0M
Q3 25
$403.0M
$899.0M
Q2 25
$411.0M
$923.0M
Q1 25
$617.0M
$936.0M
Q4 24
$532.8M
$955.0M
Q3 24
$393.7M
$1.0B
Q2 24
$402.1M
$1.0B
Q1 24
$609.4M
$1.0B
Net Profit
AVA
AVA
CBT
CBT
Q4 25
$71.0M
$73.0M
Q3 25
$29.0M
$43.0M
Q2 25
$14.0M
$101.0M
Q1 25
$79.0M
$94.0M
Q4 24
$67.2M
$93.0M
Q3 24
$18.5M
$137.0M
Q2 24
$22.9M
$109.0M
Q1 24
$71.5M
$84.0M
Gross Margin
AVA
AVA
CBT
CBT
Q4 25
24.9%
Q3 25
24.5%
Q2 25
26.4%
Q1 25
25.7%
Q4 24
24.6%
Q3 24
24.0%
Q2 24
25.2%
Q1 24
24.1%
Operating Margin
AVA
AVA
CBT
CBT
Q4 25
21.0%
15.2%
Q3 25
14.9%
15.2%
Q2 25
13.9%
18.1%
Q1 25
20.3%
17.3%
Q4 24
19.1%
16.2%
Q3 24
12.4%
15.0%
Q2 24
13.5%
16.9%
Q1 24
16.6%
15.3%
Net Margin
AVA
AVA
CBT
CBT
Q4 25
13.3%
8.6%
Q3 25
7.2%
4.8%
Q2 25
3.4%
10.9%
Q1 25
12.8%
10.0%
Q4 24
12.6%
9.7%
Q3 24
4.7%
13.7%
Q2 24
5.7%
10.7%
Q1 24
11.7%
8.2%
EPS (diluted)
AVA
AVA
CBT
CBT
Q4 25
$0.87
$1.37
Q3 25
$0.36
$0.80
Q2 25
$0.17
$1.86
Q1 25
$0.98
$1.69
Q4 24
$0.86
$1.67
Q3 24
$0.23
$2.41
Q2 24
$0.29
$1.94
Q1 24
$0.91
$1.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AVA
AVA
CBT
CBT
Cash + ST InvestmentsLiquidity on hand
$19.0M
$230.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.7B
$1.6B
Total Assets
$8.4B
$3.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AVA
AVA
CBT
CBT
Q4 25
$19.0M
$230.0M
Q3 25
$44.0M
$258.0M
Q2 25
$9.0M
$239.0M
Q1 25
$17.0M
$213.0M
Q4 24
$30.0M
$183.0M
Q3 24
$9.1M
$223.0M
Q2 24
$14.6M
$197.0M
Q1 24
$12.3M
$206.0M
Total Debt
AVA
AVA
CBT
CBT
Q4 25
Q3 25
$1.1B
Q2 25
Q1 25
Q4 24
Q3 24
$1.1B
Q2 24
Q1 24
Stockholders' Equity
AVA
AVA
CBT
CBT
Q4 25
$2.7B
$1.6B
Q3 25
$2.6B
$1.6B
Q2 25
$2.6B
$1.5B
Q1 25
$2.6B
$1.4B
Q4 24
$2.6B
$1.4B
Q3 24
$2.5B
$1.4B
Q2 24
$2.5B
$1.3B
Q1 24
$2.5B
$1.4B
Total Assets
AVA
AVA
CBT
CBT
Q4 25
$8.4B
$3.8B
Q3 25
$8.2B
$3.8B
Q2 25
$8.1B
$3.8B
Q1 25
$8.0B
$3.8B
Q4 24
$7.9B
$3.6B
Q3 24
$7.8B
$3.7B
Q2 24
$7.7B
$3.6B
Q1 24
$7.6B
$3.6B
Debt / Equity
AVA
AVA
CBT
CBT
Q4 25
Q3 25
0.70×
Q2 25
Q1 25
Q4 24
Q3 24
0.75×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AVA
AVA
CBT
CBT
Operating Cash FlowLast quarter
$75.0M
$126.0M
Free Cash FlowOCF − Capex
$-116.0M
$57.0M
FCF MarginFCF / Revenue
-21.8%
6.7%
Capex IntensityCapex / Revenue
35.8%
8.1%
Cash ConversionOCF / Net Profit
1.06×
1.73×
TTM Free Cash FlowTrailing 4 quarters
$-101.0M
$401.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AVA
AVA
CBT
CBT
Q4 25
$75.0M
$126.0M
Q3 25
$170.0M
$219.0M
Q2 25
$40.0M
$249.0M
Q1 25
$184.0M
$73.0M
Q4 24
$89.8M
$124.0M
Q3 24
$127.2M
$204.0M
Q2 24
$126.8M
$207.0M
Q1 24
$190.1M
$176.0M
Free Cash Flow
AVA
AVA
CBT
CBT
Q4 25
$-116.0M
$57.0M
Q3 25
$37.0M
$155.0M
Q2 25
$-103.0M
$188.0M
Q1 25
$81.0M
$1.0M
Q4 24
$-37.8M
$47.0M
Q3 24
$-27.0M
$112.0M
Q2 24
$-5.7M
$155.0M
Q1 24
$71.4M
$133.0M
FCF Margin
AVA
AVA
CBT
CBT
Q4 25
-21.8%
6.7%
Q3 25
9.2%
17.2%
Q2 25
-25.1%
20.4%
Q1 25
13.1%
0.1%
Q4 24
-7.1%
4.9%
Q3 24
-6.9%
11.2%
Q2 24
-1.4%
15.3%
Q1 24
11.7%
13.1%
Capex Intensity
AVA
AVA
CBT
CBT
Q4 25
35.8%
8.1%
Q3 25
33.0%
7.1%
Q2 25
34.8%
6.6%
Q1 25
16.7%
7.7%
Q4 24
23.9%
8.1%
Q3 24
39.2%
9.2%
Q2 24
33.0%
5.1%
Q1 24
19.5%
4.2%
Cash Conversion
AVA
AVA
CBT
CBT
Q4 25
1.06×
1.73×
Q3 25
5.86×
5.09×
Q2 25
2.86×
2.47×
Q1 25
2.33×
0.78×
Q4 24
1.34×
1.33×
Q3 24
6.88×
1.49×
Q2 24
5.55×
1.90×
Q1 24
2.66×
2.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AVA
AVA

Segment breakdown not available.

CBT
CBT

Reinforcement Materials$520.0M61%
Performance Chemicals$300.0M35%
Shipping And Handling$25.0M3%
Other Products And Services$4.0M0%

Related Comparisons